Searches , social queries for OMIGAPIL
Search references for OMIGAPIL. Phrases containing OMIGAPIL
See searches and references containing OMIGAPIL!
Search references for OMIGAPIL. Phrases containing OMIGAPIL
See searches and references containing OMIGAPIL!OMIGAPIL
Drug developed by Novartis
Omigapil (TCH346 or CGP3466) is a drug that was developed by Novartis and tested in clinical trials for its ability to help treat Parkinson's disease (PD)
Omigapil
Research related to Parkinson's disease
investigation as neuroprotective agents include anti-apoptotic drugs (omigapil, CEP-1347), antiglutamatergic agents, monoamine oxidase inhibitors (selegiline
Research in Parkinson's disease
Research_in_Parkinson's_disease
Treatment of Parkinson's disease
degeneration. Agents currently under investigation include antiapoptotics (omigapil, CEP-1347), antiglutamatergics, monoamine oxidase inhibitors (selegiline
Management of Parkinson's disease
Management_of_Parkinson's_disease
Investigational Parkinson's disease drugs
modulator [284] ODM-103 – catechol O-methyltransferase (COMT) inhibitor [285] Omigapil (CGP-3466; SNT-317; TCH-346) – glyceraldehyde 3 phosphate dehydrogenase
List of investigational Parkinson's disease drugs
List_of_investigational_Parkinson's_disease_drugs
Medical research on ALS
selegiline, vitamin E, and coenzyme Q); anti-apoptotic drugs (pentoxyfilline, omigapil, and minocycline); and drugs to improve mitochondria function (creatine
Amyotrophic lateral sclerosis research
Amyotrophic_lateral_sclerosis_research
travel, tourism, insurance
OMIGAPIL
OMIGAPIL
OMIGAPIL
OMIGAPIL
OMIGAPIL
OMIGAPIL
OMIGAPIL
OMIGAPIL
OMIGAPIL
travel, tourism, insurance